Atlas Trials

TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization

Clinical trial NCT02211066 · COMPLETED

Trial details

NCT number
NCT02211066
Sponsor
Hospital Clinic of Barcelona
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)
Start date
2014-10-01
Primary completion
2019-06-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.